Molecular Imaging

Latest News

Assessing The Potential of Positron Emission Mammography: An Interview with Vivianne Freitas, M.D.
Assessing the Potential of Positron Emission Mammography: An Interview with Vivianne Freitas, MD

February 12th 2024

In a recent interview, Vivianne Freitas, M.D., discussed new research findings on positron emission mammography (PEM), pertinent benefits of the technology and its potential as a viable alternative in the future to conventional imaging techniques for breast cancer screening.

Can Positron Emission Mammography Have an Impact in Diagnosing Invasive Breast Cancer?
Can Positron Emission Mammography Have an Impact in Diagnosing Invasive Breast Cancer?

February 9th 2024

Early-Stage Cervical Cancer: Is MRI, CT or PET/CT the Best Option for Diagnosing Lymph Node Metastases?
Early-Stage Cervical Cancer: Is MRI, CT or PET/CT the Best Option for Diagnosing Lymph Node Metastases?

February 9th 2024

What Post-Void MRIs May Reveal About Midline Radiotracer Activity on PSMA PET/CT
What Post-Void MRIs May Reveal About Midline Radiotracer Activity on PSMA PET/CT

January 26th 2024

Study: 18F-Flotufolastat PET Imaging Changes Treatment in 89 Percent of Patients with Prostate Cancer Recurrence
Study: 18F-Flotufolastat PET Imaging Changes Treatment in 89 Percent of Patients with Prostate Cancer Recurrence

January 25th 2024

© 2024 MJH Life Sciences

All rights reserved.